Secretory Leucoprotease Inhibitor Prevents Lipopolysaccharide-induced IκBα Degradation without Affecting Phosphorylation or Ubiquitination
Open Access
- 1 September 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (37) , 33648-33653
- https://doi.org/10.1074/jbc.m203710200
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Cathepsin B, L, and S Cleave and Inactivate Secretory Leucoprotease InhibitorJournal of Biological Chemistry, 2001
- Secretory Leukocyte Protease Inhibitor: A Macrophage Product Induced by and Antagonistic to Bacterial LipopolysaccharideCell, 1997
- Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.Journal of Clinical Investigation, 1995
- Distribution of Secretory Leukoprotease Inhibitor in the Human Nasal AirwayAmerican Review of Respiratory Disease, 1993
- Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.Journal of Clinical Investigation, 1992
- Expression of the secretory leukoprotease inhibitor gene in epithelial cells.Journal of Clinical Investigation, 1991
- Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.Journal of Clinical Investigation, 1991
- The acid‐stable proteinase inhibitor of human mucous secretions (HUSI‐I, antileukoprotease)FEBS Letters, 1986
- Biochemistry and physiological role of methionine sulfoxide residues in proteinsArchives of Biochemistry and Biophysics, 1983
- Kinetics of the inhibition of leukocyte elastase by the bronchial inhibitorBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1982